Activation of the acute inflammatory response alters cytochrome P450 expression and eicosanoid metabolism

Drug Metabolism and Disposition

Volumn 39, Issue 1, 2011, Pages 22-29

  Theken, Katherine N ^a   Deng, Yangmei ^a   Alison Kannon, M ^a   Miller, Tricia M ^b   Poloyac, Samuel M ^b   Lee, Craig R ^a  

^a University of North Carolina   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

20 HYDROXYICOSATETRAENOIC ACID; ALKANE 1 MONOOXYGENASE; CYTOCHROME P450; CYTOCHROME P450 2C24; CYTOCHROME P450 2C29; CYTOCHROME P450 2J5; CYTOCHROME P450 4A12A; CYTOCHROME P450 4A12B; CYTOCHROME P450 4F13; CYTOCHROME P450 EPOXYGENASE; DIHYDROXYICOSATRIENOIC ACID; EPOXYICOSATRIENOIC ACID; ICOSANOID; LIPOPOLYSACCHARIDE; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME METABOLISM; GENE EXPRESSION; HEART; ICOSANOID METABOLISM; INFLAMMATION; INNATE IMMUNITY; KIDNEY; LIVER; LUNG; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TIME;

ANIMALS; ARACHIDONIC ACID; CYTOCHROME P-450 ENZYME SYSTEM; EICOSANOIDS; HEART; IMMUNITY, INNATE; INFLAMMATION; KIDNEY; LIPOPOLYSACCHARIDES; LUNG; MALE; MICE; MICE, INBRED C57BL; MICROSOMES; MICROSOMES, LIVER; RNA; TANDEM MASS SPECTROMETRY; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

MUS;

EID: 78650742546     PISSN: 00909556     EISSN: 1521009X     Source Type: Journal    
DOI: 10.1124/dmd.110.035287     Document Type: Article

References (39)

1. Abdel-Razzak Z, Loyer P, Fautrel A, Gautier JC, Corcos L, Turlin B, Beaune P, and Guillouzo A (1993) Cytokines down-regulate expression of major cytochrome P-450 enzymes in adult human hepatocytes in primary culture. Mol Pharmacol 44:707-715.
2. Anwar-mohamed A, Zordoky BN, Aboutabl ME, and El-Kadi AO (2010) Alteration of cardiac cytochrome P450-mediated arachidonic acid metabolism in response to lipopolysaccharideinduced acute systemic inflammation. Pharmacol Res 61:410-418.
3. Barclay TB, Peters JM, Sewer MB, Ferrari L, Gonzalez FJ, and Morgan ET (1999) Modulation of cytochrome P-450 gene expression in endotoxemic mice is tissue specific and peroxisome proliferator-activated receptor-α dependent. J Pharmacol Exp Ther 290:1250-1257.
4. Christmas P, Jones JP, Patten CJ, Rock DA, Zheng Y, Cheng SM, Weber BM, Carlesso N, Scadden DT, Rettie AE, et al. (2001) Alternative splicing determines the function of CYP4F3 by switching substrate specificity. J Biol Chem 276:38166-38172.
5. Cui X, Wu R, Zhou M, Simms HH, and Wang P (2004) Differential expression of cytochrome P450 isoforms in the lungs of septic animals. Crit Care Med 32:1186-1191.
6. DeLozier TC, Tsao CC, Coulter SJ, Foley J, Bradbury JA, Zeldin DC, and Goldstein JA (2004) CYP2C44, a new murine CYP2C that metabolizes arachidonic acid to unique stereospecific products. J Pharmacol Exp Ther 310:845-854.
7. Deng Y, Theken KN, and Lee CR (2010) Cytochrome P450 epoxygenases, soluble epoxide hydrolase, and the regulation of cardiovascular inflammation. J Mol Cell Cardiol 48:331-341.
8. Fife KL, Liu Y, Schmelzer KR, Tsai HJ, Kim IH, Morisseau C, Hammock BD, and Kroetz DL (2008) Inhibition of soluble epoxide hydrolase does not protect against endotoxin-mediated hepatic inflammation. J Pharmacol Exp Ther 327:707-715.
9. Institute of Laboratory Animal Resources (1996) Guide for the Care and Use of Laboratory Animals, 7th ed., Institute of Laboratory Animal Resources, Commission on Life Sciences, National Research Council, Washington, DC.
10. Ishizuka T, Cheng J, Singh H, Vitto MD, Manthati VL, Falck JR, and Laniado-Schwartzman M (2008) 20-Hydroxyeicosatetraenoic acid stimulates nuclear factor-κB activation and the production of inflammatory cytokines in human endothelial cells. J Pharmacol Exp Ther 324: 103-110.
11. 4 ω-hydroxylases in rat liver and kidney. FEBS Lett 555:236-242.
12. Kubala L, Schmelzer KR, Klinke A, Kolarova H, Baldus S, Hammock BD, and Eiserich JP (2010) Modulation of arachidonic and linoleic acid metabolites in myeloperoxidase-deficient mice during acute inflammation. Free Radic Biol Med 48:1311-1320.
13. Lee CR, Bottone FG Jr, Krahn JM, Li L, Mohrenweiser HW, Cook ME, Petrovich RM, Bell DA, Eling TE, and Zeldin DC (2007) Identification and functional characterization of polymorphisms in human cyclooxygenase-1 (PTGS1). Pharmacogenet Genomics 17:145-160.
14. Liu JY, Tsai HJ, Hwang SH, Jones PD, Morisseau C, and Hammock BD (2009) Pharmacokinetic optimization of four soluble epoxide hydrolase inhibitors for use in a murine model of inflammation. Br J Pharmacol 156:284-296.
15. -Δ ΔCT method. Methods 25:402-408.
16. Luo G, Zeldin DC, Blaisdell JA, Hodgson E, and Goldstein JA (1998) Cloning and expression of murine CYP2Cs and their ability to metabolize arachidonic acid. Arch Biochem Biophys 357:45-57.
17. Luria A, Weldon SM, Kabcenell AK, Ingraham RH, Matera D, Jiang H, Gill R, Morisseau C, Newman JW, and Hammock BD (2007) Compensatory mechanism for homeostatic blood pressure regulation in Ephx2 gene-disrupted mice. J Biol Chem 282:2891-2898.
18. Ma J, Qu W, Scarborough PE, Tomer KB, Moomaw CR, Maronpot R, Davis LS, Breyer MD, and Zeldin DC (1999) Molecular cloning, enzymatic characterization, developmental expression, and cellular localization of a mouse cytochrome P450 highly expressed in kidney. J Biol Chem 274:17777-17788.
19. Miller TM, Donnelly MK, Crago EA, Roman DM, Sherwood PR, Horowitz MB, and Poloyac SM (2009) Rapid, simultaneous quantitation of mono and dioxygenated metabolites of arachidonic acid in human CSF and rat brain. J Chromatogr B Analyt Technol Biomed Life Sci 877:3991-4000.
20. Morgan ET (2001) Regulation of cytochrome P450 by inflammatory mediators: why and how? Drug Metab Dispos 29:207-212.
21. Morgan ET, Goralski KB, Piquette-Miller M, Renton KW, Robertson GR, Chaluvadi MR, Charles KA, Clarke SJ, Kacevska M, Liddle C, et al. (2008) Regulation of drug-metabolizing enzymes and transporters in infection, inflammation, and cancer. Drug Metab Dispos 36:205-216.
22. Muller DN, Schmidt C, Barbosa-Sicard E, Wellner M, Gross V, Hercule H, Markovic M, Honeck H, Luft FC, and Schunck WH (2007) Mouse Cyp4a isoforms: enzymatic properties, genderand strain-specific expression, and role in renal 20-hydroxyeicosatetraenoic acid formation. Biochem J 403:109-118.
23. Node K, Huo Y, Ruan X, Yang B, Spiecker M, Ley K, Zeldin DC, and Liao JK (1999) Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids. Science 285:1276-1279.
24. Pan J, Xiang Q, Ball S, Scatina J, Kao J, and Hong JY (2003) Lipopolysaccharide-mediated modulation of cytochromes P450 in Stat1 null mice. Drug Metab Dispos 31:392-397.
25. Pfaffl MW (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29:e45.
26. Poloyac SM, Tortorici MA, Przychodzin DI, Reynolds RB, Xie W, Frye RF, and Zemaitis MA (2004) The effect of isoniazid on CYP2E1- and CYP4A-mediated hydroxylation of arachidonic acid in the rat liver and kidney. Drug Metab Dispos 32:727-733.
27. Powell PK, Wolf I, Jin R, and Lasker JM (1998) Metabolism of arachidonic acid to 20-hydroxy- 5,8,11,14-eicosatetraenoic acid by P450 enzymes in human liver: involvement of CYP4F2 and CYP4A11. J Pharmacol Exp Ther 285:1327-1336.
28. Qu W, Bradbury JA, Tsao CC, Maronpot R, Harry GJ, Parker CE, Davis LS, Breyer MD, Waalkes MP, Falck JR, et al. (2001) Cytochrome P450 CYP2J9, a new mouse arachidonic acid omega-1 hydroxylase predominantly expressed in brain. J Biol Chem 276:25467-25479.
29. Richardson TA and Morgan ET (2005) Hepatic cytochrome P450 gene regulation during endotoxin-induced inflammation in nuclear receptor knockout mice. J Pharmacol Exp Ther 314:703-709.
30. Riddick DS, Lee C, Bhathena A, Timsit YE, Cheng PY, Morgan ET, Prough RA, Ripp SL, Miller KK, Jahan A, et al. (2004) Transcriptional suppression of cytochrome P450 genes by endogenous and exogenous chemicals. Drug Metab Dispos 32:367-375.
31. Roman RJ (2002) P-450 metabolites of arachidonic acid in the control of cardiovascular function. Physiol Rev 82:131-185.
32. Schmelzer KR, Kubala L, Newman JW, Kim IH, Eiserich JP, and Hammock BD (2005) Soluble epoxide hydrolase is a therapeutic target for acute inflammation. Proc Natl Acad Sci USA 102:9772-9777.
33. Sewer MB, Koop DR, and Morgan ET (1996) Endotoxemia in rats is associated with induction of the P4504A subfamily and suppression of several other forms of cytochrome P450. Drug Metab Dispos 24:401-407.
34. Szabo G, Romics L Jr, and Frendl G (2002) Liver in sepsis and systemic inflammatory response syndrome. Clin Liver Dis 6:1045-1066.
35. Wang H, Zhao Y, Bradbury JA, Graves JP, Foley J, Blaisdell JA, Goldstein JA, and Zeldin DC (2004) Cloning, expression, and characterization of three new mouse cytochrome P450 enzymes and partial characterization of their fatty acid oxidation activities. Mol Pharmacol 65:1148-1158.
36. Xu F, Falck JR, Ortiz de Montellano PR, and Kroetz DL (2004) Catalytic activity and isoformspecific inhibition of rat cytochrome P450 4F enzymes. J Pharmacol Exp Ther 308:887-895.
37. Yaghi A, Bend JR, Webb CD, Zeldin DC, Weicker S, Mehta S, and McCormack DG (2004) Excess nitric oxide decreases cytochrome P-450 2J4 content and P-450-dependent arachidonic acid metabolism in lungs of rats with acute pneumonia. Am J Physiol Lung Cell Mol Physiol 286:L1260-L1267.
38. Yaghi A, Bradbury JA, Zeldin DC, Mehta S, Bend JR, and McCormack DG (2003) Pulmonary cytochrome P-450 2J4 is reduced in a rat model of acute Pseudomonas pneumonia. Am J Physiol Lung Cell Mol Physiol 285:L1099-L1105.
39. Zeldin DC (2001) Epoxygenase pathways of arachidonic acid metabolism. J Biol Chem 276: 36059-36062.